跳至主要内容
临床试验/PER-053-10
PER-053-10已完成未知

PILOT STUDY: LACTOFERRIN FOR NEONATAL SEPSIS PREVENTIO

BILL & MELINDA GATES FOUNDATION,0 个研究点目标入组 208 人开始时间: 2010年9月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
208

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 1(—)
性别
All

入选标准

  • Neonates with a birth weight between 500g and 2500g
  • Neonates born in, or referred to the Neonatal Intermediate and Intensive Care Units of one of the participating hospitals in the first 72 hours of life.

排除标准

  • Neonates with underlying gastrointestinal problems that prevent oral intake.
  • Neonates with predisposing conditions that profoundly affect growth and development (chromosomal abnormalities, structural brain anomalies, severe congenital abnormalities)
  • Neonates with a family background of cow milk allergy
  • Neonates that, according to the investigator criteria, will not have the chance to complete the subsequent study visits (patients that before one month old would not be living in Lima).
  • Neonates whose parents decline to participate.

研究者

相似试验

PILOT STUDY: LACTOFERRIN FOR NEONATAL SEPSIS... | 临床试验